U Q1 2026 Earnings Narrower Loss Beats Estimates Stock Gains on Margin Progress Passage Bio Inc PASG Q1 2026 Earnings NarrowerThanExpected Loss Fuels Share Gains PDD Q4 2025 Earnings EPS Misses Estimates by 156 Shares Decline 33 ANNX Q1 2026 Earnings EPS Beat Surprise as ClinicalStage Biotech Tightens Cost Control NXE Q1 2026 Earnings Large EPS Miss Highlights Development Stage Challenges DORM Q1 2026 Earnings EPS Misses Estimates as Earnings Surprise Turns Negative